rs121913530

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate

The ENST00000311936.8(KRAS):​c.34G>T​(p.Gly12Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G12A) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

KRAS
ENST00000311936.8 missense

Scores

11
6
2

Clinical Significance

Likely pathogenic criteria provided, single submitter P:7O:2

Conservation

PhyloP100: 7.89
Variant links:
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PM1
In a hotspot region, there are 8 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 9 uncertain in ENST00000311936.8
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr12-25245350-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 45122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.908
PP5
Variant 12-25245351-C-A is Pathogenic according to our data. Variant chr12-25245351-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 12578.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-25245351-C-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KRASNM_033360.4 linkuse as main transcriptc.34G>T p.Gly12Cys missense_variant 2/6 ENST00000256078.10 NP_203524.1
KRASNM_004985.5 linkuse as main transcriptc.34G>T p.Gly12Cys missense_variant 2/5 ENST00000311936.8 NP_004976.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KRASENST00000256078.10 linkuse as main transcriptc.34G>T p.Gly12Cys missense_variant 2/61 NM_033360.4 ENSP00000256078 A1P01116-1
KRASENST00000311936.8 linkuse as main transcriptc.34G>T p.Gly12Cys missense_variant 2/51 NM_004985.5 ENSP00000308495 P4P01116-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:7Other:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Lung carcinoma Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 15, 2001- -
Lung adenocarcinoma Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingSalgia Laboratory, City of Hope-- -
not provided Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-- -
Non-small cell lung carcinoma Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineDec 07, 2007- -
Lung cancer Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingKey Laboratory of Carcinogenesis and Cancer Invasion, Central South University-- -
Gallbladder cancer Pathogenic:1
Pathogenic, no assertion criteria providedresearchInstitute of Medical Sciences, Banaras Hindu UniversityOct 30, 2020- -
RASopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 23, 2023In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly12 amino acid residue in KRAS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17704260, 26242988). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects KRAS function (PMID: 16051643). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRAS protein function. ClinVar contains an entry for this variant (Variation ID: 12578). This variant has not been reported in the literature in individuals affected with KRAS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 12 of the KRAS protein (p.Gly12Cys). -
Neoplasm Other:1
-, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalJul 31, 2024- -
Endometrial carcinoma Other:1
not provided, no classification providedliterature onlyLaboratory of Translational Genomics, National Cancer Institute-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.33
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.87
.;.;D;.
Eigen
Pathogenic
0.95
Eigen_PC
Pathogenic
0.91
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.55
T;T;T;T
M_CAP
Uncertain
0.15
D
MetaRNN
Pathogenic
0.91
D;D;D;D
MetaSVM
Uncertain
0.55
D
MutationAssessor
Uncertain
2.6
M;.;M;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.92
D
PROVEAN
Pathogenic
-7.0
D;D;D;D
REVEL
Pathogenic
0.85
Sift
Uncertain
0.0060
D;D;D;D
Sift4G
Uncertain
0.022
D;D;D;D
Polyphen
1.0
D;.;D;.
Vest4
0.90
MutPred
0.77
Gain of catalytic residue at V14 (P = 2e-04);Gain of catalytic residue at V14 (P = 2e-04);Gain of catalytic residue at V14 (P = 2e-04);Gain of catalytic residue at V14 (P = 2e-04);
MVP
0.98
MPC
2.8
ClinPred
0.99
D
GERP RS
5.7
Varity_R
0.94
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121913530; hg19: chr12-25398285; COSMIC: COSV55497469; API